Previous 10 | Next 10 |
-Orphan Drug Designation Program offers potentially up to seven years of marketing exclusivity- -NDA Submission Planned for Fourth Quarter of 2019- SAN DIEGO, July 23, 2019 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, developme...
The Piotroski-Graham value, Weekly Bounce / Lag, CFO Insider trading update and a new annual 2019 Russell 2000 Anomaly selection will also be released this week. Introduction The Weekly Breakout Forecast continues my doctoral research analysis on MDA breakout selections over more than...
SAN DIEGO, June 28, 2019 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today announ...
La Jolla Pharmaceutical ( LJPC ) announced that it had obtained positive results for its phase 2 study treating patients with a rare disease known as hereditary hemochromatosis ((HH)). These were results from an interim analysis, but based on what was shown, patients treated with LJPC-401 ...
Successful Investing takes time, discipline and patience. No matter how great the talent or effort, some things just take time: You can't produce a baby in one month by getting nine women pregnant. - Warren Buffett As much as I enjoy a good comeback story like Rocky Balboa, I'm highly enth...
Gainers: Provention Bio (NASDAQ: PRVB ) +296% . Vuzix Corporation (NASDAQ: VUZI ) +54% . Xynomic Pharmaceuticals Holdings (NASDAQ: XYN ) +46% . Tableau Software (NYSE: DATA ) +35% . Hi-Crush (NYSE: HCR ) +31% . Beyond Meat (NASDAQ: BYND ) +24% . Workhorse Group (NASDAQ: WKHS ) ...
Gainers: Stewardship Financial (NASDAQ: SSFN ) +73% . Beyond Meat (NASDAQ: BYND ) +36% . La Jolla Pharmaceutical (NASDAQ: LJPC ) +25% . ReWalk Robotics (NASDAQ: RWLK ) +26% . Neptune Wellness Solutions (NASDAQ: NEPT ) +21% . Zoom Video Communications (NASDAQ: ZM ) +21% . Horizo...
Beyond Meat (NASDAQ: BYND ) +28% as investors eye fast-food chain potential. More news on: Beyond Meat, Inc., La Jolla Pharmaceutical Company, Hancock Jaffe Laboratories, Inc., Stocks on the move, Read more ...
Gainers: La Jolla Pharmaceutical (NASDAQ: LJPC ) +87% . ContraVir Pharmaceuticals (NASDAQ: CTRV ) +74% . Ciena Corporation (NYSE: CIEN ) +24% . Cidara Therapeutics (NASDAQ: CDTX ) +21% . Dynatronics Corporation (NASDAQ: DYNT ) +16% . Stitch Fix (NASDAQ: SFIX ) +15% . Eloxx Phar...
La Jolla Pharmaceutical Company ( LJPC +14.5% ) is up on modest volume in early trade on the heels of positive interim dat a from a Phase 2 clinical trial evaluating LJPC-401 (synthetic human hepcidin) in patients with hereditary hemochromatosis , a disorder caused by the excessive abs...
News, Short Squeeze, Breakout and More Instantly...
La Jolla Pharmaceutical Company Company Name:
LJPC Stock Symbol:
NASDAQ Market:
La Jolla Pharmaceutical Company Website:
Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”), a diversified holding company with a portfolio of royalties and a growing portfolio of innovative healthcare assets, today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of L...
The biotech investment sector has always been its own market, very distinct from other sectors. So it was no surprise that when most sectors turned slowly upward after the pandemic-inspired crash, Biotech (XBI) rose 164%, exceeding the overall market (SPY) performance by triple digits. Then, a...